openPR Logo
Press release

Cardiopulmonary Bypass Equipment market is expected to grow at a CAGR of 4.13% and will reach USD 389.14 million by 2026, according to DelveInsight

08-25-2022 11:11 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Cardiopulmonary Bypass Equipment market

Cardiopulmonary Bypass Equipment market

DelveInsight has recently published "Cardiopulmonary Bypass Equipment Market Insight, Competitive Landscape & Forecast - 2026," report that covers key areas transforming the Cardiopulmonary Bypass Equipment market landscape. The Cardiopulmonary Bypass Equipment market report delivers an in-depth understanding of the Cardiopulmonary Bypass Equipment, their usage, forecasted epidemiology from 2018 to 2026, historical and forecasted Cardiopulmonary Bypass Equipment market trends.

The report also covers the Cardiopulmonary Bypass Equipment market drivers, market barriers and unmet medical in the market domain to curate the best of the opportunities in the Cardiopulmonary Bypass Equipment market.
The increase in the Cardiopulmonary Bypass Equipment market can be attributed to MedTech companies increasing their R&D to manufacture advanced cardiopulmonary products and launch better products and also because of the increase in the prevalence of cardiovascular diseases, decrease in heart muscle elasticity, change in lifestyles leading to rising in the burden of cardiovascular diseases, and increasing geriatric population.

Download a PDF Sample Report- https://www.delveinsight.com/sample-request/cardiopulmonary-bypass-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Cardiopulmonary Bypass Overview
Cardiopulmonary bypass (CPB), a heart-lung machine or pump, is a machine that temporarily takes over the function of the heart and lungs during any bloodless surgery. It maintains the circulation of blood and the oxygen content of the patient's body and is operated by perfusionists. The CPB is a form of extracorporeal circulation and is required during surgeries that require the opening of the chambers of the heart such as cardiac valve repair and/or replacement (aortic valve, mitral valve, tricuspid valve, pulmonic valve), coronary artery bypass surgery, and repair of large septal defects (atrial septal defect, ventricular septal defect, atrioventricular septal defect), among others. The machine pumps the blood and, using an oxygenator, allows red blood cells to pick up oxygen, as well as allowing carbon dioxide levels to decrease, mimicking heart and lung function.

Cardiopulmonary Bypass Equipment Market Insights
Over the years, Cardiopulmonary Bypass Equipments have helped in making significant advances in the management of severe respiratory failure as well as in the field of cardiac surgeries. The increasing number of cardiology disorders in an increasing population is anticipated to lead to a rise in demand for the equipment, thereby pushing the growth of the Cardiopulmonary Bypass Equipment market size.

Geography-wise Cardiopulmonary Bypass Equipment Market Share Analysis
Geographically, the global Cardiopulmonary Bypass Equipment analysis is done for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected to remain constant during the forecast period. However, the supremacy of North America will be evidently challenged by the Asia-Pacific market. This domination is due to the growing demand because of the growing number of surgeries, and demand for advanced technologies in Cardiopulmonary Bypass Equipment in the region. There are great opportunities for Cardiopulmonary Bypass Equipment market penetration for the countries like India, and China to the major companies already having a grip in developed regions.

Impact of COVID-19 on Cardiopulmonary Bypass Equipment Market
The demand for Cardiopulmonary Bypass Equipment is primarily motivated by the outbreak of the Covid-19 pandemic. The elective surgeries were delayed in order to curb the infection, but as the hospitals are re-opening and most cardiac surgical patients present in a more urgent manner which elevates the critical nature for intervention, which may make the surgical decision inevitable. Cardiopulmonary Bypass Equipment assists in extracorporeal circulation and physiologic gas exchange of the patient's blood for more than 6 hours. Hence, as a preventive measure, governments across the world have promoted the manufacturing of better and efficient CPB devices. This is expected to drive the cardiopulmonary bypass equipment market in the forecasted years.

Cardiopulmonary Bypass Equipment Market Segmentation
The report proffers Cardiopulmonary Bypass Equipment market segmentation as follows:
• By Product
o Heart-Lung Machines
o Oxygenators
o Autotransfusion Systems
o Others
• By Application
o Cardiovascular
o Respiratory
o Hemodialysis
o Others
• By End-User
o Hospitals
o Specialty Clinics
o Dialysis Centers
o Ambulatory Surgery Centers
• By Geography
o North America
o Europe
o Asia-Pacific
o Rest of World

Cardiopulmonary Bypass Equipment Market Report Scope
• Study Period: 2018-2026
• Key Companies: Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltda, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., and others.
• Segmentation: By Product, By Application, By End-User, and By Geography
• Geography Covered: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
• Analysis: The Cardiopulmonary Bypass Equipment market is expected to grow at a CAGR of 4.13% and will reach USD 389.14 million by 2026.

Request a PDF Sample Report- https://www.delveinsight.com/sample-request/cardiopulmonary-bypass-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Cardiopulmonary Bypass Equipment Market Report Introduction
2. Cardiopulmonary Bypass Equipment Executive summary
3. Regulatory and Patent Analysis
4. Cardiopulmonary Bypass Equipment Market Key factors analysis
5. Cardiopulmonary Bypass Equipment Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Cardiopulmonary Bypass Equipment Market
7. Cardiopulmonary Bypass Equipment Market layout
8. Cardiopulmonary Bypass Equipment Global Company Share Analysis - Key 3-5 Companies
9. Cardiopulmonary Bypass Equipment Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight

Do you have any query related to the report? If yes, visit here- https://www.delveinsight.com/report-store/cardiopulmonary-bypass-equipment-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Us
Yash
info@delveinsight.com

About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiopulmonary Bypass Equipment market is expected to grow at a CAGR of 4.13% and will reach USD 389.14 million by 2026, according to DelveInsight here

News-ID: 2715883 • Views:

More Releases from DelveInsight Business Research

Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, According to DelveInsight
Primary Biliary Cholangitis Market Expected to Experience Major Growth by 2034, …
DelveInsight's "Primary Biliary Cholangitis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Primary Biliary Cholangitis, historical and forecasted epidemiology as well as the Primary Biliary Cholangitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Primary Biliary Cholangitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Primary Biliary Cholangitis
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Advanced Renal Cell Carcinoma Pipeline 2025: Therapies, MOA Insights, and Key Cl …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Advanced Renal Cell Carcinoma Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight
Alport Syndrome Market Forecasted to Surge in Coming Years, 2024-2034 Analysis b …
DelveInsight's "Alport Syndrome Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Alport Syndrome, historical and forecasted epidemiology as well as the Alport Syndrome market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Alport Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Alport Syndrome Market Forecast https://www.delveinsight.com/sample-request/alport-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight
Angioedema Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA a …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Angioedema pipeline constitutes 20+ key companies continuously working towards developing 20+ Angioedema treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Angioedema Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Cardiopulmonary

Evolving Market Trends In The Cardiopulmonary Stress Testing Systems Industry: R …
The Cardiopulmonary Stress Testing Systems Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Cardiopulmonary Stress Testing Systems Market Size During the Forecast Period? The market size of cardiopulmonary stress testing systems has seen significant expansion in the past few years. It is
Key Trend Reshaping the Cardiopulmonary Stress Testing Systems Market in 2025: R …
What combination of drivers is leading to accelerated growth in the cardiopulmonary stress testing systems market? The projected growth of the cardiopulmonary stress testing systems market is likely fueled by the rising occurrence of cardiovascular diseases. Such diseases, a set of disorders impacting both heart and blood vessels, are becoming more frequent due to factors like unhealthy eating habits, lack of physical activity, and urbanization. These stress testing systems evaluate cardiovascular
Shaping the Cardiopulmonary Bypass Accessory Equipment Market in 2025: Advanced …
How Big Is the Cardiopulmonary Bypass Accessory Equipment Market Expected to Be, and What Will Its Growth Rate Be? The market for cardiopulmonary bypass accessory equipment has seen substantial growth in recent times. It is forecasted to expand from $15.6 billion in 2024 to $16.7 billion in 2025, with a compound annual growth rate (CAGR) of 7.0%. This impressive growth in the historic period can be linked to increased knowledge of
Cardiopulmonary Resuscitation CPR Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Cardiopulmonary Resuscitation CPR market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report reveals
Global Cardiopulmonary Stress Testing Devices Market
As per the research conducted by GME, the Global Cardiopulmonary Stress Testing Devices Market will reach USD 6.7 billion from USD 3.7 billion with a CAGR value of 5% from 2021 to 2026. The factors helping the market to grow rapidly include the increasing incidence of heart and lung disorders such as arrhythmia and heart valve imbalance, rapidly changing lifestyle, high incidence of cardiovascular and pulmonary diseases, launch of point
Cardiopulmonary Bypass Equipment Market – Insights
Cardiopulmonary bypass equipment is a machine which takes over the function of heart and lungs to maintain the circulation of blood and the oxygen content of the patient's body during coronary bypass heart surgery. This equipment also known as heart lung machine. Cardiopulmonary bypass machine consists of two main components, the pump and the oxygenator which remove oxygen-deprived blood from a patient's body and replace it with oxygen-rich blood through